Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021

SELL
$3.8 - $4.56 $1.04 Million - $1.25 Million
-274,476 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$4.33 - $6.63 $1.05 Million - $1.6 Million
241,576 Added 734.27%
274,476 $1.26 Million
Q4 2020

Feb 16, 2021

BUY
$4.87 - $17.29 $108,985 - $386,932
22,379 Added 212.71%
32,900 $199,000
Q3 2020

Nov 16, 2020

SELL
$15.08 - $27.04 $220,228 - $394,892
-14,604 Reduced 58.13%
10,521 $173,000
Q2 2020

Aug 14, 2020

SELL
$14.57 - $23.96 $387,984 - $638,030
-26,629 Reduced 51.45%
25,125 $586,000
Q1 2020

May 15, 2020

BUY
$10.27 - $21.23 $50,713 - $104,833
4,938 Added 10.55%
51,754 $768,000
Q4 2019

Feb 14, 2020

BUY
$8.36 - $23.81 $61,997 - $176,574
7,416 Added 18.82%
46,816 $958,000
Q3 2019

Nov 14, 2019

SELL
$9.83 - $14.82 $46,201 - $69,654
-4,700 Reduced 10.66%
39,400 $387,000
Q2 2019

Aug 14, 2019

BUY
$12.9 - $20.8 $568,890 - $917,280
44,100 New
44,100 $595,000
Q3 2018

Nov 14, 2018

SELL
$34.41 - $44.23 $1.11 Million - $1.43 Million
-32,400 Closed
0 $0
Q2 2018

Aug 14, 2018

SELL
$39.21 - $50.29 $345,910 - $443,658
-8,822 Reduced 21.4%
32,400 $1.27 Million
Q1 2018

May 15, 2018

SELL
$41.7 - $64.16 $345,192 - $531,116
-8,278 Reduced 16.72%
41,222 $2.03 Million
Q4 2017

Feb 14, 2018

BUY
$28.58 - $49.91 $799,439 - $1.4 Million
27,972 Added 129.93%
49,500 $2.24 Million
Q3 2017

Nov 14, 2017

BUY
$23.08 - $34.92 $496,866 - $751,757
21,528
21,528 $752,000

Others Institutions Holding ASMB

# of Institutions
1
Shares Held
16.3K
Call Options Held
0
Put Options Held
0

About ASSEMBLY BIOSCIENCES, INC.


  • Ticker ASMB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,436,900
  • Market Cap $723M
  • Description
  • Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...
More about ASMB
Track This Portfolio

Track Pdt Partners, LLC Portfolio

Follow Pdt Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pdt Partners, LLC with notifications on news.